VitaNova Life Sciences (VNOV) EBIT Margin Growth (3y) (2024 - 2026)
VitaNova Life Sciences (VNOV) EBIT Margin Growth (3y) (2024 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 81.00 |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 57.00 |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -30.00 |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -32.00 |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 234.00 |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 278.00 |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 260.00 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 928.00 |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | 25,236.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 25,236.00 |
| Oct 31, 2025 | -279.00 |
| Jul 31, 2025 | -4,545.00 |
| Apr 30, 2025 | 5,111.00 |
| Jan 31, 2025 | -4,860.00 |
| Oct 31, 2024 | 8,808.00 |